The Doctors and Drugs in Medicare Part D
lamivudine stops the replication of the human immunodeficiency virus (HIV) within important cells of the body by preventing the virus from taking over normal functions of the cell for its own purposes. Source: Iodine *
*This description is for related drug lamivudine
At a Glance: This Drug in 2014
Medicare Part D Claims
Rank: 1359 of 3362
Rank: 1118 of 3362
Rank: 1390 of 3362
Rank: 1393 of 3362
More info on related drug lamivudine »
This Drug's History
The number of Medicare prescriptions for this drug each year
The total Part D spending on this drug
Average Patient Cost
Average amount that patients without a low-income subsidy paid each year.
Note: While the rest of this page displays data from 2014, the charts above display data through 2015, from a special release by the Centers for Medicare and Medicaid Services.
Use by state
|District of Columbia||15||39||$16.1K|
About This Data
Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. The data for 2014 includes more than 1.4 billion prescriptions written by more than 1.3 million doctors, nurses and other providers. This database lists about 428,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients. Methodology »
If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to firstname.lastname@example.org and we will update your information. If you have other questions about this data, send a note to email@example.com.